Hydroxyapatite ceramic-coated femoral components in young patients followed up for 17 to 25 years
M. A. Syed, N. J. Hutt, N. Shah, A..J. Edge
Category: Furlong Clinical Results
This study reports the results of 38 total hip arthroplasties (THAs) in 33 patients aged < 50 years, using the JRI Furlong hydroxyapatite ceramic (HAC)-coated femoral component. This represents an update of previous reports of the same cohort at ten and 16 years, which were reported in 2004 and 2009, respectively. We describe the survival, radiological and functional outcomes at a mean follow-up of 21 years (17 to 25). Of the surviving 34 THAs, one underwent femoral revision for peri-prosthetic fracture after 21 years, and one patient (one hip) was lost to follow-up. Using aseptic loosening as the end-point, 12 hips (31.5%) needed acetabular revision but none needed femoral revision, demonstrating 100% survival (95% confidence interval 89 to 100).
In young patients with high demands, the Furlong HAC–coated femoral component gives excellent long-term results.
Bone Joint J 2015;97-B:749–54.